"If you have a pandemic, unheard of infections and deaths in India and Brazil and widespread cases worldwide, a drug that has been investigated for over a year at government RBLs, and yet you still can't fill a trial quickly one has to look at the process and see something is messed up (being politically correct) to a major degree."
Pete, looks like your estimate was off since you expected enrollment is near 100%. You really can't blame American politics since the majority of enrollment takes place in Russia. Try to look within the company if you can't find a blame outside.
If you have a pandemic, unheard of infections and deaths in India and Brazil and widespread cases worldwide, a drug that has been investigated for over a year at government RBLs with remarkably outstanding results, and yet you still can't fill a trial quickly one has to look at the process and see something is messed up (being politically correct) to a major degree.
I totally agree. In a Banana Republic the little guy gets squashed while the big guys skate right through, completely protected from any liability of course. Eventually facts will matter.
In response to:
“This trial progression says more about the state of medicine and the roadblocks put up for new drugs than it does regarding the worthiness of Brilacidin IMO. “